Orbimed Advisors Takes a Major Stake in Ambit Biosciences Corp (AMBI)

In the smart money’s world, Samuel Isaly’s Orbimed Advisors reported a purchase of some 2.1 million shares of Ambit Biosciences Corp (NASDAQ:AMBI) in a 13D filing with the SEC’s Edgar system. In...... (read more)